{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:15:31Z","timestamp":1783376131499,"version":"3.54.6"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,28]]},"DOI":"10.1038\/s41388-026-03859-w","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:50:19Z","timestamp":1781358619000},"page":"2865-2877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR\/NF-\u03baB-mediated macrophage inflammatory response"],"prefix":"10.1038","volume":"45","author":[{"given":"Chengfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-663X","authenticated-orcid":false,"given":"Junjun","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanggui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-2333","authenticated-orcid":false,"given":"Hongping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"3859_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"3859_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: A Cancer J Clin"},{"key":"3859_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101315","volume":"4","author":"X Xing","year":"2023","unstructured":"Xing X, Hu E, Ouyang J, Zhong X, Wang F, Liu K, et al. Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy. Cell Rep Med. 2023;4:101315.","journal-title":"Cell Rep Med"},{"key":"3859_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.apsb.2024.10.016","volume":"15","author":"J Sun","year":"2025","unstructured":"Sun J, Yuan H, Sun L, Zhao L, Wang Y, Hou C, et al. Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8(+) T-cell-mediated antitumor immunity in liver cancer. Acta Pharm Sin B. 2025;15:188\u2013204.","journal-title":"Acta Pharm Sin B"},{"key":"3859_CR5","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.59717\/j.xinn-med.2025.100125","volume":"3","author":"L Shen","year":"2025","unstructured":"Shen L, Jiang Y, Lu L, Cui M, Xu J, Li C, et al. Dynamic prognostication and treatment planning for hepatocellular carcinoma: a machine learning-enhanced survival study using multi-centric data. Innov Med. 2025;3:100125.","journal-title":"Innov Med"},{"key":"3859_CR6","doi-asserted-by":"crossref","unstructured":"Igarashi Y, Akiyama Y, Shimada S, Watanabe S, Hatano M, Kodera K, et al. Identification and clinical implications of endogenous retrovirus elements suppressed by SETDB1 in hepatocellular carcinoma. JHEP Rep : Innov Hepatol. 2024;7:101307.","DOI":"10.1016\/j.jhepr.2024.101307"},{"key":"3859_CR7","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.7150\/thno.104557","volume":"15","author":"W Bi","year":"2025","unstructured":"Bi W, Li X, Jiang Y, Gao T, Zhao H, Han Q, et al. Tumor-derived exosomes induce neutrophil infiltration and reprogramming to promote T-cell exhaustion in hepatocellular carcinoma. Theranostics. 2025;15:2852\u201369.","journal-title":"Theranostics"},{"key":"3859_CR8","doi-asserted-by":"publisher","first-page":"e100186","DOI":"10.1136\/egastro-2025-100186","volume":"3","author":"B Bueloni","year":"2025","unstructured":"Bueloni B, Garcia Fernandez de Barrena M, Avila MA, Bayo J, Mazzolini G. Epigenetic mechanisms involved in hepatocellular carcinoma development and progression. eGastroenterology. 2025;3:e100186.","journal-title":"eGastroenterology"},{"key":"3859_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20240134","volume":"3","author":"Y Shi","year":"2025","unstructured":"Shi Y, Fan R. Racing toward the future of chronic hepatitis B management: Achieving functional cure and enhancing hepatocellular carcinoma surveillance through precision medicine. Interdiscip Med. 2025;3:e20240134.","journal-title":"Interdiscip Med"},{"key":"3859_CR10","doi-asserted-by":"crossref","unstructured":"Zhang W, Zhangyuan G, Wang F, Jin K, Shen H, Zhang L, et al. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity. 2021;54:1168\u201385.","DOI":"10.1016\/j.immuni.2021.04.027"},{"key":"3859_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","volume":"22","author":"YH Yeo","year":"2025","unstructured":"Yeo YH, Abdelmalek M, Khan S, Moylan CA, Rodriquez L, Villanueva A, et al. Current and emerging strategies for the prevention of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2025;22:173\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3859_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.","journal-title":"Nat Rev Dis Prim"},{"key":"3859_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/gutjnl-2019-319227","volume":"70","author":"A Esparza-Baquer","year":"2021","unstructured":"Esparza-Baquer A, Labiano I, Sharif O, Agirre-Lizaso A, Oakley F, Rodrigues PM, et al. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms. Gut. 2021;70:1345\u201361.","journal-title":"Gut"},{"key":"3859_CR14","doi-asserted-by":"crossref","unstructured":"Yang H, Wu H, Zhou H, Liu S, Xu M, Wu D, et al. The nuclear transport machinery in hepatocellular carcinoma: From precancerous lesions to progression and therapeutic targeting. Genes Dis. 2026;102065. In Press.","DOI":"10.1016\/j.gendis.2026.102065"},{"key":"3859_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.mucimm.2024.12.014","volume":"18","author":"C Wang","year":"2024","unstructured":"Wang C, Yu T, Wang Y, Xu M, Wang J, Zhao Y, et al. Targeting the EP2 receptor ameliorates inflammatory bowel disease in mice by enhancing the immunosuppressive activity of T(reg) cells. Mucosal Immunol. 2024;18:418\u201330.","journal-title":"Mucosal Immunol"},{"key":"3859_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57977-2","volume":"16","author":"YT Wang","year":"2025","unstructured":"Wang YT, Branche E, Xie J, McMillan RE, Ana-Sosa-Batiz F, Lu HH, et al. Zika but not Dengue virus infection limits NF-\u03baB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells. Nat Commun. 2025;16:2695.","journal-title":"Nat Commun"},{"key":"3859_CR17","doi-asserted-by":"crossref","unstructured":"Acu\u00f1a-Pilarte K, Reichert EC, Green YS, Halberg LM, Golkowski M, Maguire KM, et al. HAF prevents hepatocyte apoptosis and progression to MASH and HCC through transcriptional regulation of the NF-\u03baB pathway. Hepatology (Baltimore, Md). 2025;82:438\u201353","DOI":"10.1097\/HEP.0000000000001070"},{"key":"3859_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101329","volume":"7","author":"C Zhang","year":"2025","unstructured":"Zhang C, Zhou Y, Hu M, Pan Y, Chen X, Sun Q, et al. PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating NF-\u03baB\/IL-6\/STAT3-dependent TCA cycle. JHEP Rep. 2025;7:101329.","journal-title":"JHEP Rep"},{"key":"3859_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41418-020-00608-8","volume":"28","author":"H Qiao","year":"2021","unstructured":"Qiao H, Jiang T, Mu P, Chen X, Wen X, Hu Z, et al. Cell fate determined by the activation balance between PKR and SPHK1. Cell Death Differ. 2021;28:401\u201318.","journal-title":"Cell Death Differ"},{"key":"3859_CR20","doi-asserted-by":"crossref","unstructured":"Guo SK, Suo J, Huang Y, Yin X, Wang J, Li L, et al. Therapeutic circRNA aptamer alleviates PKR-associated osteoarthritis. Sci Bull. 2025;70:2232\u20136.","DOI":"10.1016\/j.scib.2025.02.027"},{"key":"3859_CR21","unstructured":"Zhang G, Zhang L, Zhao D, Liu X, Li W, Yan C, et al. Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage. Ann Rheumatic Dis. 2024:ard-2024-226057."},{"key":"3859_CR22","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1038\/s41388-021-02117-5","volume":"40","author":"L Yin","year":"2021","unstructured":"Yin L, Zeng Y, Zeng R, Chen Y, Wang TL, Rodabaugh KJ, et al. Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Oncogene. 2021;40:6772\u201385.","journal-title":"Oncogene"},{"key":"3859_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/hep.31195","volume":"72","author":"J Ding","year":"2020","unstructured":"Ding J, Zhao J, Huan L, Liu Y, Qiao Y, Wang Z, et al. Inflammation-induced long intergenic noncoding RNA (LINC00665) increases malignancy through activating the double-stranded RNA-activated protein kinase\/nuclear factor kappa B pathway in hepatocellular carcinoma. Hepatol (Balt, Md). 2020;72:1666\u201381.","journal-title":"Hepatol (Balt, Md)"},{"key":"3859_CR24","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1074\/jbc.275.13.9157","volume":"275","author":"T Tsutsumi","year":"2000","unstructured":"Tsutsumi T, Ushiro H, Kosaka T, Kayahara T, Nakano K. Proline- and alanine-rich Ste20-related kinase associates with F-actin and translocates from the cytosol to cytoskeleton upon cellular stresses. J Biol Chem. 2000;275:9157\u201362.","journal-title":"J Biol Chem"},{"key":"3859_CR25","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1073\/pnas.1802339115","volume":"115","author":"Taylor CAt","year":"2018","unstructured":"CAt Taylor, An SW, Kankanamalage SG, Stippec S, Earnest S, Trivedi AT, et al. OSR1 regulates a subset of inward rectifier potassium channels via a binding motif variant. Proc Natl Acad Sci USA. 2018;115:3840\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3859_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmet.2011.07.009","volume":"14","author":"JA McCormick","year":"2011","unstructured":"McCormick JA, Mutig K, Nelson JH, Saritas T, Hoorn EJ, Yang CL, et al. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab. 2011;14:352\u201364.","journal-title":"Cell Metab"},{"key":"3859_CR27","doi-asserted-by":"publisher","first-page":"13881","DOI":"10.1093\/nar\/gkae1099","volume":"52","author":"Y Xu","year":"2024","unstructured":"Xu Y, Li C, Yin H, Nowsheen S, Xu X, Kang W, et al. STK39-mediated amplification of \u03b3-H2A.X promotes homologous recombination and contributes to PARP inhibitor resistance. Nucleic acids Res. 2024;52:13881\u201395.","journal-title":"Nucleic acids Res"},{"key":"3859_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103223","volume":"24","author":"X Hao","year":"2021","unstructured":"Hao X, Zhang Y, Lu Y, Han G, Rong D, Sun G, et al. STK39 enhances the progression of Cholangiocarcinoma via PI3K\/AKT pathway. iScience. 2021;24:103223.","journal-title":"iScience"},{"key":"3859_CR29","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.7150\/thno.48112","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, et al. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1\/ERK signaling pathway. Theranostics. 2021;11:2108\u201322.","journal-title":"Theranostics"},{"key":"3859_CR30","first-page":"4","volume":"12","author":"J Zhuang","year":"2026","unstructured":"Zhuang J, Hu C, Lei L, Sang Y, Sun Q, Xia H. Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis. Hepatoma Res. 2026;12:4.","journal-title":"Hepatoma Res"},{"key":"3859_CR31","doi-asserted-by":"crossref","unstructured":"Feng Z-Y, Xu F-G, Liu Y, Xu H-J, Wu F-B, Chen X-B, et al. The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma. Hepatoma Res. 2021;7:3.","DOI":"10.20517\/2394-5079.2020.107"},{"key":"3859_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.apsb.2024.12.034","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Xu P, Wang Y, Chen X, Pan Y, Ma Z, et al. STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation. Acta Pharm Sin B. 2025;15:1535\u201351.","journal-title":"Acta Pharm Sin B"},{"key":"3859_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/HEP.0000000000000423","volume":"78","author":"W Chen","year":"2023","unstructured":"Chen W, Sun Y, Chen S, Ge X, Zhang W, Zhang N, et al. Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatol (Balt, Md). 2023;78:1118\u201332.","journal-title":"Hepatol (Balt, Md)"},{"key":"3859_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41575-018-0033-6","volume":"15","author":"ZJ Brown","year":"2018","unstructured":"Brown ZJ, Heinrich B, Greten TF. Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol. 2018;15:536\u201354.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3859_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101056","volume":"6","author":"B Moeckli","year":"2024","unstructured":"Moeckli B, Delaune V, Gilbert B, Peloso A, Oldani G, El Hajji S, et al. Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome. JHEP Rep : Innov Hepatol. 2024;6:101056.","journal-title":"JHEP Rep : Innov Hepatol"},{"key":"3859_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115354119","volume":"119","author":"H Yu","year":"2022","unstructured":"Yu H, Peng C, Zhang C, Stoian AMM, Tazi L, Brennan G, et al. Maladaptation after a virus host switch leads to increased activation of the pro-inflammatory NF-\u03baB pathway. Proc Natl Acad Sci USA. 2022;119:e2115354119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3859_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1158\/0008-5472.CAN-23-1796","volume":"84","author":"M Mu","year":"2024","unstructured":"Mu M, Huang CX, Qu C, Li PL, Wu XN, Yao W, et al. Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy. Cancer Res. 2024;84:841\u201354.","journal-title":"Cancer Res"},{"key":"3859_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104800","volume":"157","author":"Y Gao","year":"2020","unstructured":"Gao Y, Fan X, Li N, Du C, Yang B, Qin W, et al. CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma. Pharm Res. 2020;157:104800.","journal-title":"Pharm Res"},{"key":"3859_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","volume":"73","author":"X Jin","year":"2019","unstructured":"Jin X, Ding D, Yan Y, Li H, Wang B, Ma L, et al. Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-\u03baB Activation and PD-L1 Expression. Mol cell. 2019;73:22\u201335.e26.","journal-title":"Mol cell"},{"key":"3859_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hep.31249","volume":"73","author":"L Gu","year":"2021","unstructured":"Gu L, Zhu Y, Lin X, Lu B, Zhou X, Zhou F, et al. The IKK\u03b2-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatol (Balt, Md). 2021;73:160\u201374.","journal-title":"Hepatol (Balt, Md)"},{"key":"3859_CR41","doi-asserted-by":"crossref","unstructured":"Kim SY, Ha JW, Na MJ, Jeon S, Yoon JH, Park WS, et al. Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma. Exper Mol Med. 2025;57:1164-76.","DOI":"10.1038\/s12276-025-01459-4"},{"key":"3859_CR42","doi-asserted-by":"crossref","unstructured":"Moris D, Martinino A, Schiltz S, Allen PJ, Barbas A, Sudan D, et al. Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians. CA: A Cancer J Clin. 2025;75:498\u2013527.","DOI":"10.3322\/caac.70018"},{"key":"3859_CR43","doi-asserted-by":"crossref","unstructured":"Xu W, Weng J, Zhao Y, Xie P, Xu M, Liu S, et al. FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma. J Immunotherapy Cancer. 2025;13:e011648.","DOI":"10.1136\/jitc-2025-011648"},{"key":"3859_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216106","volume":"558","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhu R, Zhou M, Liu J, Dong K, Zhao S, et al. Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma. Cancer Lett. 2023;558:216106.","journal-title":"Cancer Lett"},{"key":"3859_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101380","volume":"7","author":"P Huang","year":"2025","unstructured":"Huang P, Rodriguez-Matos FJ, Qi J, Trehan R, Myojin Y, Zhu XB, et al. Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer. JHEP Rep : Innov Hepatol. 2025;7:101380.","journal-title":"JHEP Rep : Innov Hepatol"},{"key":"3859_CR46","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1158\/1078-0432.CCR-18-0504","volume":"24","author":"H Yang","year":"2018","unstructured":"Yang H, Mao W, Rodriguez-Aguayo C, Mangala LS, Bartholomeusz G, Iles LR, et al. Paclitaxel sensitivity of ovarian cancer can be enhanced by knocking down pairs of kinases that regulate MAP4 phosphorylation and microtubule stability. Clin Cancer Res : J Am Assoc Cancer Res. 2018;24:5072\u201384.","journal-title":"Clin Cancer Res : J Am Assoc Cancer Res"},{"key":"3859_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.livres.2025.11.004","volume":"9","author":"S Hao","year":"2025","unstructured":"Hao S, Yao H, Yu H, Wang L, Yu T, Xia H, et al. Targeting lactic acidosis in the tumor microenvironment: Enhancing TACE efficacy in hepatocellular carcinoma. Liver Res. 2025;9:273\u201385.","journal-title":"Liver Res"},{"key":"3859_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.100071.4","volume":"13","author":"QT Trac","year":"2025","unstructured":"Trac QT, Huang Y, Erkers T, \u00d6stling P, Bohlin A, Osterroos A, et al. Pathway activation model for personalized prediction of drug synergy. eLife. 2025;13:RP100071.","journal-title":"eLife"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03859-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:04:59Z","timestamp":1783375499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03859-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":48,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026,7,28]]}},"alternative-id":["3859"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03859-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In this study, all animal experiments complied with institutional guidelines and received approval from the Institutional Ethics Committee of Nanjing Medical University and Southeast University (Approval No. IACUC-1909005 and IACUC-2025-0220059).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"All authors consent to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}